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EDITORIAL
Improving completeness and transparency of reporting in clinical trials using 
the template for intervention description and replication (TIDieR) checklist will 
benefit the physiotherapy profession
the trial may have been wasted. These potentially wasted 
resources may be extensive, including direct trial costs (e.g. 
payment of researchers, consumables), use of infrastructure 
(e.g. clinic space, equipment), human resources (e.g. ethics 
committee review, granting body review) and the good-
will of patients who agree to participate. There is growing 
evidence that waste in clinical research has to be reduced.
[6] When the list of resources involved in a single study is 
considered, improving the reproducibility of interventions 
through better reporting could markedly reduce waste in 
research.[7]
The TIDieR checklist and guide were developed to 
improve the reporting of interventions in any evaluative 
study, including RCTs.[8] The checklist contains 12 items and 
was developed as an extension to the CONSORT 2010 [9] 
and SPIRIT 2013 [10] statements to provide further guidance 
for authors in reporting key information in trial reports. The 
TIDieR items include: name of the intervention; interven-
tion rationale for essential elements; intervention materials 
and details about how to access them; description of the 
intervention procedures; details of intervention providers; 
mode of delivery of intervention; location of intervention 
delivery and key infrastructure; details about the number, 
duration, intensity and dose of intervention sessions; details 
of any intervention tailoring; any intervention modifications 
throughout the study; and details of intervention fidelity 
assessment, monitoring and level achieved. The TIDieR 
checklist will help improve the quality of intervention 
reporting if it is used by study authors, journal editors, peer 
reviewers, ethics committees and funding agencies. A copy 
of the checklist is available at: http://www.equator-network.
org/reporting-guidelines/tidier/.
In summary, incomplete reporting of interventions in 
physiotherapy studies is an important problem and The 
Journal of Manual and Manipulative Therapy endorses the 
use of the TIDieR checklist as a potential solution. The 
responsibility for improving intervention reporting extends 
beyond the authors of individual trials to journal editors 
and others who can mandate the use of the TIDieR checklist 
to combat this problem. Mandating the use of the TIDieR 
checklist will help authors more accurately describe their 
interventions. This will allow clinicians to more accurately 
generalize and apply the study’s findings and researchers 
to synthesize and replicate the evidence.
The Journal of Manual and Manipulative Therapy supports 
the decision of the International Society of Physiotherapy 
Journal Editors (ISPJE) and will request completion of the 
Evidence-supported practice requires that physiotherapists 
incorporate high-quality clinical research on treatment effi-
cacy into their clinical decision-making process.[1] If clinical 
interventions are not adequately reported in the literature, 
physiotherapists are unable to determine how to imple-
ment a study’s interventions or to determine if the find-
ings of the study are applicable to the patients that they are 
treating. Previous studies have reported that the incomplete 
description of interventions is a problem in reports of RCTs 
in many health areas.[2–4] One of these studies [4] exam-
ined 133 trials of non-pharmacological interventions. The 
experimental intervention was inadequately described in 
over 60% of the trials and descriptions of the control inter-
ventions were even worse.
A recent study [5] sought to determine if the descriptions 
of the physiotherapy interventions in a sample of 200 RCTs 
published in 2013 were adequately described. Overall, the 
interventions were poorly described. For the intervention 
groups, about one-quarter of the trials did not fulfil at least 
half of the criteria. Reporting for the control groups was 
even worse, with around three-quarters of the trials not ful-
filling at least half of the criteria. These findings suggest that 
for the majority of the physiotherapy trials, clinicians and 
researchers would be unable to replicate the interventions.
Describing a treatment may seem like a simple task, but 
physiotherapy interventions can be very complex. Some 
interventions are multi-modal, involving the use of manual 
techniques, consumable materials, equipment, education, 
training and feedback. Some interventions are tailored to 
each patient’s specific health state, including the patient’s 
immediate response to the application of the treatment. 
When the intervention involves a course of treatments, the 
intensity or dose may progress over time. The descriptions 
of physiotherapy interventions in RCTs often do not capture 
the details of all of these complexities.
If researchers fail to comprehensively report all aspects 
of the interventions, the trials results cannot be generalized 
and incorporated into clinical practice. More concerning is 
that the intervention could be implemented incorrectly. 
Incorrect implementation may make the treatment ineffec-
tive, wasting the clinician’s and patient’s time, health care 
resources and potentially harming the patient. Inadequate 
reporting of interventions also poses a barrier to incorporat-
ing a trial’s results into synthesis research such as meta-anal-
yses, systematic reviews and clinical practice guidelines, 
making the findings of these resources questionable. This 
means that the resources that were invested in conducting 
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TIDieR checklist for clinical trials starting in January, 2017. 
Submitting authors are encouraged to use the TIDieR 
checklist with the CONSORT checklist and report these in 
Appendices to the manuscript to ensure that any interven-
tions described in their manuscript are accurately reported. 
However, submitting authors will not be required to submit 
the checklist. The editor will make an initial decision about 
the suitability of the manuscript for peer review. For manu-
scripts that are suitable for review, the editor will check the 
manuscript against the checklist to ensure that all items are 
fully reported. Manuscripts that do not report all relevant 
aspects of the intervention will be returned to the authors 
to address the gaps in reporting before the manuscript will 
progress to peer review. Submitting authors with questions 
about the checklist are invited to contact the journal’s edi-
torial team at jm.brismee@ttuhsc.edu.
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